Evidence map›Paper›PMID 35241464›Full record

ArticleBMJ open2022

Urban scaling of opioid overdose deaths in the USA: a cross-sectional study in three periods between 2005 and 2017.

Pricila H Mullachery, Stephen Lankenau, Ana V Diez Roux, Ran Li, Rosie Mae Henson, Usama Bilal

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pricila H MullacheryDornsife School of Public Health, Urban Health Collaborative, Drexel University, Philadelphia, Pennsylvania, USA phm32@drexel.edu.ORCID 0000-0003-4758-3875
Stephen LankenauDornsife School of Public Health, Department of Community Health and Prevention, Drexel University, Philadelphia, Pennsylvania, USA.
Ana V Diez RouxDornsife School of Public Health, Urban Health Collaborative, Drexel University, Philadelphia, Pennsylvania, USA.
Ran LiDornsife School of Public Health, Urban Health Collaborative, Drexel University, Philadelphia, Pennsylvania, USA.
Rosie Mae HensonDornsife School of Public Health, Department of Health Management and Policy, Drexel University, Philadelphia, Pennsylvania, USA.
Usama BilalDornsife School of Public Health, Urban Health Collaborative, Drexel University, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-9868-7773

Funding

The Health Consequences of Urban ScalingDP5OD026429 · OD · DREXEL UNIVERSITY · PI BILAL, USAMA · 2018 to 2022
$2.7M
NIH HHS DP5 OD026429
6 · The paper itself

Abstract

objectivesTo describe the association between population size, population growth and opioid overdose deaths-overall and by type of opioid-in US commuting zones (CZs) in three periods between 2005 and 2017. SETTINGS: 741 CZs covering the entirety of the US CZs are aggregations of counties based on commuting patterns that reflect local economies.

participantsWe used mortality data at the county level from 2005 to 2017 from the National Center for Health Statistics. OUTCOME: Opioid overdose deaths were defined using underlying and contributory causes of death codes from the International Classification of Diseases, 10th revision (ICD-10). We used the underlying cause of death to identify all drug poisoning deaths. Contributory cause of death was used to classify opioid overdose deaths according to the three major types of opioid, that is, prescription opioids, heroin and synthetic opioids other than methadone.

resultsOpioid overdose deaths were disproportionally higher in largely populated CZs. A CZ with 1.0% larger population had 1.10%, 1.10%, and 1.16% higher opioid death count in 2005-2009, 2010-2014, and 2015-2017, respectively. This pattern was largely driven by a high number of deaths involving heroin and synthetic opioids, particularly in 2015-2017. Population growth over time was associated with lower age-adjusted opioid overdose mortality rate: a 1.0% increase in population over time was associated with 1.4% (95% CI: -2.8% to 0.1%), 4.5% (95% CI: -5.8% to -3.2%), and 1.2% (95% CI: -4.2% to 1.8%) lower opioid overdose mortality in 2005-2009, 2010-2014, and 2015-2017, respectively. The association between positive population growth and lower opioid mortality rates was stronger in larger CZs.

conclusionsOpioid overdose mortality in the USA was disproportionately higher in mid-sized and large CZs, particularly those affected by declines in population over time, regardless of the region where they are located.

Indexed as

Drug OverdoseOpiate OverdoseAnalgesics, OpioidCross-Sectional StudiesHeroinHumansUnited StatesAnalgesics, OpioidHeroinepidemiologypublic healthsubstance misuse

Identifiers

PMID35241464
PMCPMC8896002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.